Trademark: 90627262
Word
ZYNSGRI
Status
Dead
Status Code
606
Status Date
Monday, September 4, 2023
Serial Number
90627262
Mark Type
4000
Filing Date
Tuesday, April 6, 2021
Published for Opposition
Tuesday, December 7, 2021
Abandoned Date
Monday, September 4, 2023

Trademark Owner History
Travere Therapeutics, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Trademark Events
Sep 5, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 4, 2023
Abandonment - No Use Statement Filed
Feb 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 1, 2023
Sou Extension 2 Granted
Feb 1, 2023
Sou Extension 2 Filed
Feb 1, 2023
Sou Teas Extension Received
Jul 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2022
Sou Extension 1 Granted
Jul 27, 2022
Sou Extension 1 Filed
Jul 27, 2022
Sou Teas Extension Received
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 4, 2021
Approved For Pub - Principal Register
Oct 29, 2021
Assigned To Examiner
Jul 15, 2021
New Application Office Supplied Data Entered
Apr 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24